These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. N-ras mutations are associated with poor prognosis and increased risk of leukemia in myelodysplastic syndrome. Paquette RL; Landaw EM; Pierre RV; Kahan J; Lübbert M; Lazcano O; Isaac G; McCormick F; Koeffler HP Blood; 1993 Jul; 82(2):590-9. PubMed ID: 8329714 [TBL] [Abstract][Full Text] [Related]
6. Prevalence of N-ras mutations in children with myelodysplastic syndromes and acute myeloid leukemia. Lübbert M; Mirro J; Kitchingman G; McCormick F; Mertelsmann R; Herrmann F; Koeffler HP Oncogene; 1992 Feb; 7(2):263-8. PubMed ID: 1549347 [TBL] [Abstract][Full Text] [Related]
7. Lack of noncanonical RAS mutations in cytogenetically normal acute myeloid leukemia. Reuter CW; Krauter J; Onono FO; Bunke T; Damm F; Thol F; Wagner K; Göhring G; Schlegelberger B; Heuser M; Ganser A; Morgan MA Ann Hematol; 2014 Jun; 93(6):977-82. PubMed ID: 24737308 [TBL] [Abstract][Full Text] [Related]
8. ras oncogene activation and occupational exposures in acute myeloid leukemia. Taylor JA; Sandler DP; Bloomfield CD; Shore DL; Ball ED; Neubauer A; McIntyre OR; Liu E J Natl Cancer Inst; 1992 Nov; 84(21):1626-32. PubMed ID: 1433344 [TBL] [Abstract][Full Text] [Related]
9. The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome. Lu D; Nounou R; Beran M; Estey E; Manshouri T; Kantarjian H; Keating MJ; Albitar M Cancer; 2003 Jan; 97(2):441-9. PubMed ID: 12518368 [TBL] [Abstract][Full Text] [Related]
10. Correlation of N-ras point mutations with specific chromosomal abnormalities in primary myelodysplastic syndrome. de Souza Fernandez T; Menezes de Souza J; Macedo Silva ML; Tabak D; Abdelhay E Leuk Res; 1998 Feb; 22(2):125-34. PubMed ID: 9593469 [TBL] [Abstract][Full Text] [Related]
11. The prognostic impact of K-RAS mutations in adult acute myeloid leukemia patients treated with high-dose cytarabine. Ahmad EI; Gawish HH; Al Azizi NM; Elhefni AM Onco Targets Ther; 2011; 4():115-21. PubMed ID: 21792317 [TBL] [Abstract][Full Text] [Related]
12. Analysis of ras gene mutations in acute myeloid leukemia by the polymerase chain reaction and oligonucleotide probes. Chin YM; Bosco JJ; Koh CL Singapore Med J; 1992 Feb; 33(1):48-50. PubMed ID: 1598607 [TBL] [Abstract][Full Text] [Related]
13. Mutations of the ras proto-oncogenes in childhood monosomy 7. Neubauer A; Shannon K; Liu E Blood; 1991 Feb; 77(3):594-8. PubMed ID: 1991170 [TBL] [Abstract][Full Text] [Related]
14. Mutations in ras proto-oncogenes are associated with lower mdr1 gene expression in adult acute myeloid leukaemia. Schaich M; Ritter M; Illmer T; Lisske P; Thiede C; Schäkel U; Mohr B; Ehninger G; Neubauer A Br J Haematol; 2001 Feb; 112(2):300-7. PubMed ID: 11167822 [TBL] [Abstract][Full Text] [Related]
15. Mutation of Ki-ras and N-ras oncogenes in myelodysplastic syndromes. Lyons J; Janssen JW; Bartram C; Layton M; Mufti GJ Blood; 1988 Jun; 71(6):1707-12. PubMed ID: 3285909 [TBL] [Abstract][Full Text] [Related]
16. N-ras mutations in adult de novo acute myelogenous leukemia: prevalence and clinical significance. Radich JP; Kopecky KJ; Willman CL; Weick J; Head D; Appelbaum F; Collins SJ Blood; 1990 Aug; 76(4):801-7. PubMed ID: 2200539 [TBL] [Abstract][Full Text] [Related]